| Identification | Back Directory | [Name]
3',5'-DI-O-BENZOYLTHYMIDINE | [CAS]
35898-30-7 | [Synonyms]
thymidine 3',5'-dibenzoate
3',5'-DI-O-BENZOYLTHYMIDINE
3'-O,5'-O-Dibenzoylthymidine
benzoic acid [(2R,3S,5R)-3-benzoyloxy-5-(5-methyl-2,4-dioxo-1-pyrimidinyl)-2-oxolanyl]methyl ester | [EINECS(EC#)]
252-786-1 | [Molecular Formula]
C24H22N2O7 | [MDL Number]
MFCD00047486 | [MOL File]
35898-30-7.mol | [Molecular Weight]
450.44 |
| Hazard Information | Back Directory | [Uses]
3’,5’-Di-O-benzoyl thymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|